Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

183
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
183
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

145
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
145
Analgesia and Pain Management01:25

Analgesia and Pain Management

403
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
403
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

411
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
411
Drug Dependence01:17

Drug Dependence

954
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
954
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

358
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
358

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spectral clustering identifies patterns of chiropractic care in a national longitudinal cohort.

JAMIA open·2026
Same author

"It's Part of Dialysis": Lived Experiences of Transportation Challenges Among Patients and Staff in In-Center Hemodialysis.

The journal of nephrology social work·2026
Same author

Rebuilding the foundation: recommendations from the Summit to Revitalize Primary Care (Rev PC).

BMC proceedings·2026
Same author

Association Between Transportation and Home Dialysis Transition: Retrospective Cohort Study.

Kidney medicine·2026
Same author

Prostate Specific Antigen Ordering After Implementation of a Point-of-Care Reminder to Discuss Screening.

Journal of the American Board of Family Medicine : JABFM·2026
Same author

Dose trajectories associated with non-fatal overdose among patients co-prescribed opioids and benzodiazepines: Retrospective cohort study.

Drug and alcohol dependence·2025

Related Experiment Video

Updated: May 15, 2025

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.2K

Unsupervised machine learning identifies opioid taper reversal patterns in a longitudinal cohort (2008-2018).

Monika Ray1,2, Joshua J Fenton2,3, Patrick S Romano1,2

  • 1Department of Internal Medicine, School of Medicine, University of California Davis, Davis, California, United States of America.

PLOS Digital Health
|April 7, 2025
PubMed
Summary

Rapid opioid dose tapering in chronic pain patients can increase adverse events. Unsupervised AI identified 10 patient clusters with varying taper speeds, revealing that faster tapering, especially to zero, correlated with more adverse events and deaths.

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.5K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.1K

Related Experiment Videos

Last Updated: May 15, 2025

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.2K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.5K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.1K

Area of Science:

  • Pain Management
  • Pharmacology
  • Artificial Intelligence in Healthcare

Background:

  • Long-term opioid therapy is common for chronic pain, but dose reduction strategies are not well understood.
  • Rapid opioid dose tapering is linked to adverse events, yet patient heterogeneity requires further investigation.
  • Understanding patient subgroups is crucial for safe opioid dose management and tapering protocols.

Purpose of the Study:

  • To analyze opioid dose management and patient characteristics in a diverse national cohort undergoing tapering.
  • To identify distinct patient subpopulations based on opioid tapering patterns using artificial intelligence.
  • To compare adverse events and outcomes across different opioid tapering profiles.

Main Methods:

  • Utilized spectral clustering, an unsupervised artificial intelligence (AI) approach, on national claims data (2008-2018).
  • Analyzed 30,932 patients with stable high opioid doses (≥50 MME) undergoing a tapering period.
  • Identified 10 distinct patient clusters based on tapering magnitude, velocity, duration, and endpoint.

Main Results:

  • Ten patient clusters were identified, similar at baseline but differing in tapering characteristics.
  • A cluster (42%) with moderately rapid tapering to zero dose showed higher drug-related events, mental health issues, and deaths compared to slow tapering (55%).
  • Clusters with taper reversals had adverse event rates similar to slow tapering groups.

Conclusions:

  • Unsupervised AI effectively identifies clinically meaningful patterns and subpopulations in opioid tapering data.
  • Tapering velocity, duration, and final dose are critical factors influencing patient outcomes.
  • Findings emphasize the need for patient-centered care and tailored tapering protocols, especially considering taper reversals.